A detailed history of Vanguard Group Inc transactions in Clearside Biomedical, Inc. stock. As of the latest transaction made, Vanguard Group Inc holds 2,839,978 shares of CLSD stock, worth $2.5 Million. This represents 0.0% of its overall portfolio holdings.

Number of Shares
2,839,978
Previous 2,839,978 -0.0%
Holding current value
$2.5 Million
Previous $3.69 Million 2.3%
% of portfolio
0.0%
Previous 0.0%

Shares

8 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2024

Aug 13, 2024

BUY
$1.08 - $1.58 $377,116 - $551,707
349,182 Added 14.02%
2,839,978 $3.69 Million
Q1 2024

May 10, 2024

BUY
$1.2 - $2.02 $377,376 - $635,249
314,480 Added 14.45%
2,490,796 $3.81 Million
Q4 2023

Feb 14, 2024

BUY
$0.68 - $1.18 $6,413 - $11,128
9,431 Added 0.44%
2,176,316 $2.55 Million
Q4 2022

Feb 10, 2023

BUY
$1.0 - $1.5 $1,208 - $1,812
1,208 Added 0.06%
2,166,885 $2.43 Million
Q1 2022

May 13, 2022

SELL
$1.35 - $2.88 $12,791 - $27,288
-9,475 Reduced 0.44%
2,165,677 $4.96 Million
Q4 2021

Feb 14, 2022

SELL
$2.72 - $5.72 $8,214 - $17,274
-3,020 Reduced 0.14%
2,175,152 $5.98 Million
Q3 2021

Nov 12, 2021

BUY
$4.83 - $7.2 $348,156 - $518,990
72,082 Added 3.42%
2,178,172 $13.1 Million
Q2 2021

Aug 13, 2021

BUY
$2.32 - $5.38 $4.89 Million - $11.3 Million
2,106,090 New
2,106,090 $10.3 Million

Others Institutions Holding CLSD

About Clearside Biomedical, Inc.


  • Ticker CLSD
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 60,190,700
  • Market Cap $53M
  • Description
  • Clearside Biomedical, Inc., a biopharmaceutical company, focuses on the revolutionizing the delivery of therapies to the back of the eye through the suprachoroidal space. The company offers XIPERE, a triamcinolone acetonide suprachoroidal injectable suspension for the treatment of uveitis macular edema. It also develops CLS-AX, an axitinib injec...
More about CLSD
Track This Portfolio

Track Vanguard Group Inc Portfolio

Follow Vanguard Group Inc and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Vanguard Group Inc, based on Form 13F filings with the SEC.

News

Stay updated on Vanguard Group Inc with notifications on news.